{
    "clinical_study": {
        "@rank": "156238", 
        "arm_group": [
            {
                "arm_group_label": "Fish oil (Omega-3 fatty acid)", 
                "arm_group_type": "Experimental", 
                "description": "2 capsules/day of ProOmega providing 650mg EPA and 450mg DHA"
            }, 
            {
                "arm_group_label": "Soybean oil", 
                "arm_group_type": "Placebo Comparator", 
                "description": "2 capsules/day"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study to determine whether Fish oil (Omega-3 Fatty Acid) supplementation\n      has an impact on inflammation and lean body mass in older adults. The investigators expect\n      that Fish oil supplementation will reduce inflammation and prevent the loss of lean mass\n      compared to placebo."
        }, 
        "brief_title": "\ufeff\ufeffOmega-3 Fatty Acid Supplementation in Older Adults", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Inflammation", 
        "condition_browse": {
            "mesh_term": "Inflammation"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  60 years of age or over\n\n        Exclusion Criteria:\n\n          -  Fish, seafood allergies, nut allergies, soy allergies\n\n          -  Habitual (>1/week) fish or seafood consumption\n\n          -  Current Omega-3 supplement use\n\n          -  Gastrointestinal problems\n\n          -  Current anti-inflammatory medication use\n\n          -  Current anticoagulant medication use"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "60 Years"
        }, 
        "enrollment": {
            "#text": "0", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 10, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01666392", 
            "org_study_id": "#2232", 
            "secondary_id": "#2232"
        }, 
        "intervention": [
            {
                "arm_group_label": "Fish oil (Omega-3 fatty acid)", 
                "description": "Omega-3 fatty acid, Eicosapentaenoic acid+docosahexaenoic acid in capsule form", 
                "intervention_name": "Omega-3 fatty acid", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "ProOmega (Nordic Naturals)"
            }, 
            {
                "arm_group_label": "Soybean oil", 
                "description": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Omega-3 fatty acid", 
            "Fish oil", 
            "Muscle mass", 
            "Muscle strength", 
            "Older adults", 
            "Circulating inflammatory cytokines", 
            "Skeletal muscle mass", 
            "Upper body strength", 
            "Lower body strength"
        ], 
        "lastchanged_date": "October 8, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Memphis", 
                    "country": "United States", 
                    "state": "Tennessee", 
                    "zip": "38152"
                }, 
                "name": "Department of Health and Sport Sciences, The University of Memphis"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Impact of \ufeff\ufeffOmega-3 Fatty Acid Supplementation on Markers of Inflammation and Lean Body Mass in Older Adults", 
        "other_outcome": {
            "description": "To determine the effectiveness of fish oil supplementation, we measure EPA and DHA Omega-3 fatty acid levels", 
            "measure": "EPA and DHA", 
            "safety_issue": "No", 
            "time_frame": "At baseline and at 3 month endpoint"
        }, 
        "overall_official": {
            "affiliation": "The University of Memphis", 
            "last_name": "Zsolt Murlasits, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Withdrawn", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Inflammatory marker", 
                "measure": "C-Reactive protein", 
                "safety_issue": "No", 
                "time_frame": "At baseline testing and at 3 month endpoint"
            }, 
            {
                "description": "Inflammatory cytokine", 
                "measure": "IL6", 
                "safety_issue": "No", 
                "time_frame": "At baseline and at 3 month endpoint"
            }, 
            {
                "description": "Inflammatory cytokine", 
                "measure": "TNF\u03b1", 
                "safety_issue": "No", 
                "time_frame": "At baseline and at 3 month endpoint"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01666392"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Memphis", 
            "investigator_full_name": "Zsolt Murlasits", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "The amount of skeletal muscle mass and fat mass and their ration will be determined.", 
                "measure": "Skeletal muscle mass/body composition", 
                "safety_issue": "No", 
                "time_frame": "At baseline testing and at 3 month endpoint"
            }, 
            {
                "description": "Measurement of maximum strength in the leg press exercise", 
                "measure": "Lower body muscular strength", 
                "safety_issue": "No", 
                "time_frame": "At baseline and at 3 month endpoint"
            }, 
            {
                "description": "Measurement of maximum strength in the chest press exercise", 
                "measure": "Upper body muscular strength", 
                "safety_issue": "No", 
                "time_frame": "At baseline and at 3 month endpoint"
            }
        ], 
        "source": "University of Memphis", 
        "sponsors": {
            "collaborator": {
                "agency": "Nordic Naturals", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "University of Memphis", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "August 2012"
    }
}